NCT07083492

Brief Summary

Validation of non-invasive measurement of zinc protoporphyrin for detection of iron deficiency in pregnancy. In addition, the impact of iron deficiency on the incidence of postpartum depression, restless legs syndrome, obstetric complications and quality of life will be examined.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Nov 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Nov 2022Dec 2026

First Submitted

Initial submission to the registry

November 12, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

November 15, 2022

Completed
2.7 years until next milestone

First Posted

Study publicly available on registry

July 24, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

4.1 years

First QC Date

November 12, 2022

Last Update Submit

July 23, 2025

Conditions

Keywords

Zinc protoporphyrinNon-invasive detectionObstetric anesthesiaPatient blood management

Outcome Measures

Primary Outcomes (1)

  • Accuracy of non-invasive zinc protoporphyrin for the detection of iron deficiency in pregnancy

    To validate accuracy of non-invasively measured ZnPP for detection of iron deficiency in pregnancy at prespecified timepoints

    through study completion, up to 3 months postpartum

Secondary Outcomes (4)

  • Influence of iron status on quality of life of pregnant women

    through study completion, up to 3 months postpartum

  • Influence of iron status on incidence of postpartum depression

    through study completion, up to 3 months postpartum

  • Influence of iron status on incidence of restless legs syndrome among pregnant women

    through study completion, up to 3 months postpartum

  • Influence of iron status on incidence of preterm birth

    peripartum ( about 20 weeks of pregnancy until approximately 6 weeks after delivery. )

Study Arms (1)

pregnant women

Diagnostic Test: non-invasive measurement of zink protoporphyrin

Interventions

validation of non-invasive measurement of zink protoporphyrin

Also known as: blood samples, questionnaires
pregnant women

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

pregnant women ≥ 18 years

You may qualify if:

  • any timepoint during or up to 3 months after pregnancy
  • age ≥ 18 years
  • written informed consent

You may not qualify if:

  • previous participation in this study
  • refusal of blood sampling
  • incapacity to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Würzburg

Würzburg, Bavaria, 97080, Germany

RECRUITING

Biospecimen

Retention: NONE RETAINED

blood samples

MeSH Terms

Conditions

Anemia, Iron-DeficiencyPostpartum HemorrhageDepression, PostpartumIron Deficiencies

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Peter Kranke, MD, MBA

CONTACT

Tobias Schlesinger, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. P. Kranke

Study Record Dates

First Submitted

November 12, 2022

First Posted

July 24, 2025

Study Start

November 15, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 24, 2025

Record last verified: 2025-07

Locations